References
- Bregengaard C., Diness V. and Hedner U. (1993) Effect of recombinant factor VIIa on endotoxin-induced disseminated intravasular coagula-tion in rabbits. Thrombosis and Haemostasis, 69, 749.
- Drife J. (1997) Mangement of primary postpartum haemorrage. British Journal of Obstetrics and Gynaecology, 104, 275–277.
- O'Connell N.M., Perry D.J., Hodgson A.J., et al. (2003) Recombination FVIIa in the management of uncontrolled haemorrage. Transfusion, 43, 1711–1716.
- Roberts H.R. (1998) Clinical experience with activated factor VII: focus on safety aspects. Blood Coagulation and Fibrinolysis, 9(Supplement), S115—S118.
- Segal S., Shemesh I.Y., Blumenthal R., et al. (2003) Treatment of obstetric haemorrhage with recombinant activated factor VII (rFVIIa). Archives of Gynecology and Obstetrics, 268, 266–267.
- Vlot A.J., Ton E., Mackaay A.J.C., Kramer M.H.H. and Gaillard C.A.J.M. (2000) Treatment of a severely bleeding patient without pre-existing coagulopathy with activated factor VII. American Journal of Medicine, 108, 421–422.
- White B., McHale J., Ravi N. et al. (1999) Successful use of recombinant FVIIa (NovoSeven) in the management of intractable post-surgical intra-abdominal haemorrage. British Journal of Hae-matology, 107, 677–682.